Aurobindo Pharma today said it has received final approval from the US health regulator for its generic Nevirapine tablets and oral suspension used for treating human immunodeficiency virus (HIV).
The
Aurobindo Pharma, which has been facing ire of the USFDA coupled with drop in sales, hopes to launch three-four products along with pharma major Pfizer in three months. This
Drug firm Aurobindo Pharma today posted a consolidated net loss of Rs 28. 54 crore for the quarter ended December 31 2011 primarily on account of foreign exchange
The IT department conducted searches at Aurobindo Pharma corporate office and 13 manufacturing units. The searches are likely to go on for a day or two
Drug firm Aurobindo Pharma today said it has received final approval from the US health regulator to manufacture and market generic Gabapentin tablets, used in the treatment of central nervous
City based-drug maker Aurobindo Pharma Ltd is eyeing overseas and domestic acquisitions to achieve a $2 billion turnover by 2014, a top executive of the company said.
Aurobindo Pharma Chairman
Mid-sized Indian drugmakers are expected to post steady to strong revenue growth in April-June, riding healthy domestic and overseas demand, but higher would crimp margins.
Companies like Lupin, Cadila Healthcare,
Global pharmaceutical giant Pfizer Inc has sued the Hyderabad-based drug firm Aurobindo Pharma Ltd alleging patent infringement pertaining to its cholesterol lowering drug Lipitor. Lipitor, which is among the best
Stay informed on our latest news!
